|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Current assets | |||||
| Cash and cash equivalents | |||||
| Prepaid expenses | |||||
| Total current assets | |||||
| Non-current Asset | |||||
| Deferred offering costs | |||||
| Cash and Investments held in Trust Account | |||||
| Total Non-current Asset | |||||
| Total Assets | |||||
| Liabilities and Shareholders’ Equity | |||||
| Current Liability | |||||
| Accrued expenses | |||||
| Due to Sponsor | |||||
| Promissory Note - Related party | |||||
| Total Current Liability | |||||
| Ordinary shares subject to possible redemption, 5,750,000 and 0 nil shares issued and outstanding at redemption value of $10.12 and nil as of December 31, 2025 and 2024, respectively. | |||||
| Commitments and Contingencies – (see Note 6) | |||||
| Shareholders’ Equity | |||||
| Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 1,885,871 and 1,885,871 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||
| Additional paid-in capital | |||||
| Retained earning (Accumulated deficit) | |||||
| Total Shareholders’ Equity | |||||
| Total Liabilities, Ordinary shares subject to possible redemption and Shareholders’ Equity |
Loading...
